12-15 May 2025
Congress Center HamburgHamburg, Germany Matthias MüllnerCEO at bespark*bioSpeaker
Profile
Matthias graduated from the University of Vienna in the field of virology and molecular biology. In 2011 he joined Themis Bioscience, a biotech start-up specialized in the development of vaccines against emerging infectious diseases. At Themis he established the Technical Operations Department and led the group for over a decade as part of the executive management team. In early 2023, Matthias co-founded bespark*bio to continue his passion for developing sophisticated manufacturing processes for viral vector-based medicines.
Agenda Sessions
The Valley of Death: Mastering CMC Challenges in the Development of Novel Biotherapeutics
, 09:00View Session